Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology

[1]  E. Goodall,et al.  Genetics of Familial Amyotrophic Lateral Sclerosis , 2012 .

[2]  C. Angelinetta,et al.  Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord , 2010, Neurobiology of Aging.

[3]  M. Piccinini,et al.  TDP‐43 Redistribution is an Early Event in Sporadic Amyotrophic Lateral Sclerosis , 2010, Brain pathology.

[4]  D. Vocadlo,et al.  Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS , 2009, Neuroscience Letters.

[5]  Robert Lalonde,et al.  Exploratory activity and motor coordination in old versus middle-aged C57BL/6J mice. , 2009, Archives of gerontology and geriatrics.

[6]  A. Goate,et al.  VCP Mutations Causing Frontotemporal Lobar Degeneration Disrupt Localization of TDP-43 and Induce Cell Death* , 2009, Journal of Biological Chemistry.

[7]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[8]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[9]  V. Olkkonen,et al.  ALS‐linked P56S‐VAPB, an aggregated loss‐of‐function mutant of VAPB, predisposes motor neurons to ER stress‐related death by inducing aggregation of co‐expressed wild‐type VAPB , 2009 .

[10]  S. Sakoda,et al.  Nuclear TAR DNA Binding Protein 43 Expression in Spinal Cord Neurons Correlates With the Clinical Course in Amyotrophic Lateral Sclerosis , 2009, Journal of neuropathology and experimental neurology.

[11]  K. Talbot,et al.  TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy , 2008, BMC Neuroscience.

[12]  J. Ngsee,et al.  FFAT rescues VAPA-mediated inhibition of ER-to-Golgi transport and VAPB-mediated ER aggregation , 2008, Journal of Cell Science.

[13]  Ryuichi Nakajima,et al.  Comprehensive behavioral phenotyping of calpastatin-knockout mice , 2008, Molecular Brain.

[14]  S. Lev,et al.  Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport. , 2008, Molecular biology of the cell.

[15]  T. Yaksh,et al.  Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death , 2008, Proceedings of the National Academy of Sciences.

[16]  J. Trojanowski,et al.  Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2008, The American journal of pathology.

[17]  G. Schellenberg,et al.  A90V TDP‐43 variant results in the aberrant localization of TDP‐43 in vitro , 2008, FEBS letters.

[18]  Anthony W. Zoghbi,et al.  The Amyotrophic Lateral Sclerosis 8 Protein VAPB Is Cleaved, Secreted, and Acts as a Ligand for Eph Receptors , 2008, Cell.

[19]  P. Golshani,et al.  A Drosophila Model of ALS: Human ALS-Associated Mutation in VAP33A Suggests a Dominant Negative Mechanism , 2008, PloS one.

[20]  Christos G. Gkogkas,et al.  VAPB interacts with and modulates the activity of ATF6. , 2008, Human molecular genetics.

[21]  J. Trojanowski,et al.  Disturbance of Nuclear and Cytoplasmic TAR DNA-binding Protein (TDP-43) Induces Disease-like Redistribution, Sequestration, and Aggregate Formation* , 2008, Journal of Biological Chemistry.

[22]  B. McConkey,et al.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.

[23]  Murray Grossman,et al.  TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis , 2008, The Lancet Neurology.

[24]  A. Kakita,et al.  TDP‐43 mutation in familial amyotrophic lateral sclerosis , 2008, Annals of neurology.

[25]  J. Morris,et al.  TDP‐43 A315T mutation in familial motor neuron disease , 2008, Annals of neurology.

[26]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[27]  Tom Misteli,et al.  TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression , 2008, Proceedings of the National Academy of Sciences.

[28]  Y. Koh,et al.  hVAPB, the causative gene of a heterogeneous group of motor neuron diseases in humans, is functionally interchangeable with its Drosophila homologue DVAP-33A at the neuromuscular junction. , 2008, Human molecular genetics.

[29]  G. Rouleau,et al.  Genetics of familial amyotrophic lateral sclerosis , 2008, Neurology.

[30]  C. Hoogenraad,et al.  Motor Neuron Disease-Associated Mutant Vesicle-Associated Membrane Protein-Associated Protein (VAP) B Recruits Wild-Type VAPs into Endoplasmic Reticulum-Derived Tubular Aggregates , 2007, The Journal of Neuroscience.

[31]  J. Morris,et al.  TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. , 2007, The American journal of pathology.

[32]  E. Pioro,et al.  Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS , 2007, Neuroscience Letters.

[33]  W. Kamphorst,et al.  TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations. , 2007, Brain : a journal of neurology.

[34]  J. Trojanowski,et al.  Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations , 2007, Annals of neurology.

[35]  A. Kakita,et al.  TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation , 2007, Acta Neuropathologica.

[36]  C. Zhang,et al.  A method comparison in monitoring disease progression of G93A mouse model of ALS , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[37]  H. Akiyama,et al.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.

[38]  K. Okamoto,et al.  Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis , 2006, Journal of the Neurological Sciences.

[39]  P. Walter,et al.  Intracellular signaling by the unfolded protein response. , 2006, Annual review of cell and developmental biology.

[40]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[41]  I. Nishimoto,et al.  Characterization of Amyotrophic Lateral Sclerosis-linked P56S Mutation of Vesicle-associated Membrane Protein-associated Protein B (VAPB/ALS8)* , 2006, Journal of Biological Chemistry.

[42]  D. Cleveland,et al.  ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors , 2006, Neuron.

[43]  Robert H. Brown,et al.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.

[44]  F. Baralle,et al.  TDP43 depletion rescues aberrant CFTR exon 9 skipping , 2006, FEBS letters.

[45]  C. Shaw,et al.  ALS2/Alsin Regulates Rac-PAK Signaling and Neurite Outgrowth* , 2005, Journal of Biological Chemistry.

[46]  J. Glass,et al.  The Wld S gene modestly prolongs survival in the SOD1G93A fALS mouse , 2005, Neurobiology of Disease.

[47]  Christopher J. R. Loewen,et al.  A Highly Conserved Binding Site in Vesicle-associated Membrane Protein-associated Protein (VAP) for the FFAT Motif of Lipid-binding Proteins* , 2005, Journal of Biological Chemistry.

[48]  S. Lev,et al.  Differential Regulation of Endoplasmic Reticulum Structure through VAP-Nir Protein Interaction* , 2005, Journal of Biological Chemistry.

[49]  T. Gillingwater,et al.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.

[50]  K. Lau,et al.  The Neuronal Adaptor Protein X11β Reduces Amyloid β-Protein Levels and Amyloid Plaque Formation in the Brains of Transgenic Mice* , 2004, Journal of Biological Chemistry.

[51]  E. F. Stanley,et al.  A Syntaxin 1, Gαo, and N-Type Calcium Channel Complex at a Presynaptic Nerve Terminal: Analysis by Quantitative Immunocolocalization , 2004, The Journal of Neuroscience.

[52]  J. Cooper,et al.  The Neuronal Adaptor Protein X11α Reduces Aβ Levels in the Brains of Alzheimer's APPswe Tg2576 Transgenic Mice* , 2003, Journal of Biological Chemistry.

[53]  Ammar Al-Chalabi,et al.  Neurofilaments and neurological disease. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[54]  N. M. Reddy,et al.  Higher order arrangement of the eukaryotic nuclear bodies , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  P. Hiesinger,et al.  Drosophila VAP-33A Directs Bouton Formation at Neuromuscular Junctions in a Dosage-Dependent Manner , 2002, Neuron.

[56]  E Vorontsova,et al.  Motor and associative deficits in D2 dopamine receptor knockout mice , 2002, International Journal of Developmental Neuroscience.

[57]  Robert Kapsa,et al.  Presymptomatic motor neuron loss and reactive astrocytosis in the SOD1 mouse model of amyotrophic lateral sclerosis , 2001, Muscle & nerve.

[58]  E. Kandel,et al.  Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[59]  E. Fisher,et al.  Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment , 1997, Mammalian Genome.

[60]  D. Borchelt,et al.  ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions , 1997, Neuron.

[61]  E. Kandel,et al.  A VAMP-binding protein from Aplysia required for neurotransmitter release. , 1995, Science.

[62]  D Harrich,et al.  Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs , 1995, Journal of virology.

[63]  S. McHanwell,et al.  The sizes of motoneurons supplying hindlimb muscles in the mouse , 1981, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[64]  M. Bonduelle,et al.  [Familial amyotrophic lateral sclerosis]. , 1959, La Presse medicale.

[65]  E. Buratti,et al.  Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. , 2008, Frontiers in bioscience : a journal and virtual library.

[66]  K. Lau,et al.  The neuronal adaptor protein X11beta reduces amyloid beta-protein levels and amyloid plaque formation in the brains of transgenic mice. , 2004, The Journal of biological chemistry.

[67]  J. Cooper,et al.  The neuronal adaptor protein X11alpha reduces Abeta levels in the brains of Alzheimer's APPswe Tg2576 transgenic mice. , 2003, The Journal of biological chemistry.

[68]  M. Tavakoli.  Disease progression in amyotrophic lateral sclerosis , 2002, The European Journal of Health Economics.